Novartis Pharma's Smoking Cessation Aid Nicotinell Now Conditionally Listed on Japan NHI Price List.Tokyo, Japan, June 5, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Novartis Pharma announced on June 1 that its proprietary smoking cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. aid, Nicotinell TTS (1) See text-to-speech. (2) (Transaction Tracking System) Software that monitors a transaction until completion. In the event of a hardware or software failure, it ensures that the database is brought back to its former state before the attempt to , has been listed on the National Health Insurance (NHI NHI abbr. National Health Insurance ) Price List on a conditional basis. The cost of this transdermal nicotine patch can be reimbursed by the NHI when prescribed for the treatment of nicotine addiction. The numbers of facilities and patients that are subject to the NHI reimbursement system are limited. The company expects that Nicotinell TTS will help smokers struggling with smoking cessation. Initially released in Switzerland in 1990, Nicotinell TTS is now approved in over 60 countries worldwide. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion